210 participants
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2022-01-24
- Completion:
- 2025-05-27
Conditions
- Mantle Cell Lymphoma
Interventions
- DRUG
No Results Yet